ZYUS Life Sciences Corporation (TSXV:ZYUS)
Canada flag Canada · Delayed Price · Currency is CAD
0.4950
+0.0450 (10.00%)
At close: May 6, 2026

ZYUS Life Sciences Financials Overview

Millions CAD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-0.11000.350.3-
Revenue Growth
--15.80%-99.86%17.79%--
Gross Profit
0.050.050.130.17-0.23-
Operating Income
-17.77-18.91-34.99-42.14-18.79-0.23
Net Income
-20.83-21.73-33.81-42.59-24.660.35
Earnings Per Share
-0.27-0.28-0.47-0.76-0.640.07
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.120.231.95.850.218.59
Total Debt
21.9415.9412.169.8134.90
Net Cash (Debt)
-21.83-15.7-10.26-3.95-34.698.59
Net Cash Growth
-----1.69%
Net Cash Per Share
-0.28-0.20-0.14-0.07-0.901.71

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-7.79-9.23-9.88-17.95-9.57-0.33
Capital Expenditures
--0.01-0.05-0.28-0.56-
Free Cash Flow
-7.79-9.24-9.92-18.23-10.13-0.33
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-39.66%12345.70%26819.10%48.72%-77.85%-
Operating Margin
15661.00%-4669630.00%-7274840.00%-12006.00%-6306.04%-
Pretax Margin
18360.31%-5365679.01%-7462162.16%-13800.28%-8293.62%-
Profit Margin
18360.30%-5365680.00%-7028070.00%-12134.20%-8274.16%-
FCF Margin
6865.07%-2281730.00%-2062790.00%-5193.45%-3400.67%-

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-----16.57
PS Ratio
96.51138395.00145315.00181.66109.91-